Drugs / Influenza Trivalent Inactivated vaccines
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00649883 Comparator | Jan → Apr 2008 | influenza | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Trivalent Inactivated vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00649883 ↗ |
| Modality | Vaccine | “active control influenza vaccine” NCT00649883 ↗ |
| Route | Intramuscular | “administered four weeks apart intramuscularly (IM) in the deltoid muscle preferably of the non-dominant arm” NCT00649883 ↗ |